Totally agree. With FDA behind it, the business is derisked and open to a whole new market. This should hopefully take out some of the seasonal lumpiness in revenue from the business while generating more cash for them to move onto the vitaligo part of the business as they have stated. Exciting times for long term holders with competant management I'm not to concerned about price gyrations.....The fundamentals of the business just improved threefold with FDA.....
Price targets, page-37
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.96 |
Change
0.000(0.00%) |
Mkt cap ! $698.8M | |||
| Open | High | Low | Value | Volume |
| $14.03 | $14.13 | $13.93 | $654.6K | 46.74K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25 | $13.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.01 | 140 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| CUV (ASX) Chart |